17089-501 NDC - GUNA FEMALE SUPPORT (LILIUM LANCIFOLIUM WHOLE FLOWERING - SUS SCROFA OVARY - SUS SCROFA PITUITARY GLAND - SEPIA OFFICINALIS JUICE - ADENOSINE CYCLIC PHOSPHATE - PULSATILLA VULGARIS - SUS SCROFA HYPOTHALAMUS - SUS SCROFA ADRENAL GLAND - SUS SCROFA PANCREAS - MAGNESIUM PHOSPHATE DIBASIC TRIHYDRATE)

Drug Information

  • Product NDC: 17089-501
  • Proprietary Name: GUNA FEMALE SUPPORT
  • Non Proprietary Name: lilium lancifolium whole flowering - sus scrofa ovary - sus scrofa pituitary gland - sepia officinalis juice - adenosine cyclic phosphate - pulsatilla vulgaris - sus scrofa hypothalamus - sus scrofa adrenal gland - sus scrofa pancreas - magnesium phosphate dibasic trihydrate
  • Active Ingredient(s): 6 [hp_X]/30mL ADENOSINE CYCLIC PHOSPHATE; 6 [hp_X]/30mL LILIUM LANCIFOLIUM WHOLE FLOWERING; 10 [hp_X]/30mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 8 [hp_X]/30mL PULSATILLA VULGARIS; 10 [hp_X]/30mL SEPIA OFFICINALIS JUICE; 30 [hp_X]/30mL SUS SCROFA ADRENAL GLAND; 30 [hp_X]/30mL SUS SCROFA HYPOTHALAMUS; 6 [hp_X]/30mL SUS SCROFA OVARY; 30 [hp_X]/30mL SUS SCROFA PANCREAS; 30 [hp_X]/30mL SUS SCROFA PITUITARY GLAND
  • Administration Route(s): ORAL
  • Dosage Form(s): SOLUTION/ DROPS
  • Pharmacy Class(es): Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:2/17/2021

Package Information

No. Package Code Package Description Billing Unit
117089-501-181 BOTTLE, DROPPER in 1 BOX (17089-501-18) / 30 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-501The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEGUNA FEMALE SUPPORTThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMElilium lancifolium whole flowering - sus scrofa ovary - sus scrofa pituitary gland - sepia officinalis juice - adenosine cyclic phosphate - pulsatilla vulgaris - sus scrofa hypothalamus - sus scrofa adrenal gland - sus scrofa pancreas - magnesium phosphate dibasic trihydrateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE2/17/2021This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEADENOSINE CYCLIC PHOSPHATE; LILIUM LANCIFOLIUM WHOLE FLOWERING; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLANDAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 10; 8; 10; 30; 30; 6; 30; 30 
ACTIVE INGRED UNIT[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL 
PHARM CLASSESCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 1/16/2026

Previous Code
Next Code